Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Smoking Cessation 1 Motor Activity 1 Lung Neoplasms 1 Inflammation 1

Interventions

Specimen Handling 629 pembrolizumab 559 Magnetic Resonance Spectroscopy 539 Carboplatin 423 Cyclophosphamide 371 Cisplatin 371 Biopsy 357 Paclitaxel 304 Nivolumab 301 Gemcitabine 299 Radiotherapy 270 Bevacizumab 238 Dexamethasone 207 fludarabine 205 Docetaxel 189 durvalumab 178 atezolizumab 176 Oxaliplatin 172 Fluorouracil 167 venetoclax 164 Rituximab 164 Pemetrexed 162 Radiation 159 Doxorubicin 159 Capecitabine 158 Radiosurgery 147 Etoposide 137 Ipilimumab 134 Leucovorin 133 Lenalidomide 130

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

cytisine × 90 days × Clear all

NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡